Cancer Market Research Reports & Industry Analysis

... 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French ... others. Test volume and sales forecasts for 40 tumor markers performed in French hospitals. Current instrumentation technologies and feature comparison of ...

... 40 tables, and presents a comprehensive analysis of the German hospital tumor marker testing market, including: Major issues pertaining to the German ... others. Test volume and sales forecasts for 40 tumor markers performed in German hospitals. Current instrumentation technologies and feature comparison of ...

... 38 tables, and presents a comprehensive analysis of the Italian hospital tumor marker testing market, including: Major issues pertaining to the Italian ... others. Test volume and sales forecasts for 40 tumor markers performed in Italian hospitals. Current instrumentation technologies and feature comparison of ...

... 42 tables, and presents a comprehensive analysis of the Japanese hospital tumor marker testing market, including: Major issues pertaining to the Japanese ... others. Test volume and sales forecasts for 40 tumor markers performed in Japanese hospitals. Current instrumentation technologies and feature comparison of ...

... 41 tables, and presents a comprehensive analysis of the Spanish hospital tumor marker testing market, including: Major issues pertaining to the Spanish ... others. Test volume and sales forecasts for 40 tumor markers performed in Spanish hospitals. Current instrumentation technologies and feature comparison of ...

... a comprehensive analysis of the UK hospital tumor marker testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key ... . Test volume and sales forecasts for 40 tumor markers performed in UK hospitals. Current instrumentation technologies and feature comparison of ...

... pages, 50 tables, and presents a comprehensive analysis of the US hospital tumor market testing market, including: Major issues pertaining to the US ... others. Test volume and sales forecasts for 40 tumor markers performed in US hospitals. Current instrumentation technologies and feature comparison of leading ...

... history and personal history are linked to the growth of breast cancer. The global breast cancer market is likely to grow strongly in the coming years driven ... countries, long term side effects of drugs. The report “Global Breast Cancer Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics ...

... markets for novel products, diagnostics and therapeutics development. The report covers the regulatory environment, current and new technologies, ovarian cancer incidence, market projections and market ... covers global and regional markets for ovarian cancer diagnostics and therapies, providing reasons for ...

... opinion leader (KOL) insights on the latest events happening in the prostate cancer space. Topics covered include expert opinions on the FDA approval ... inhibitor Erleada (apalutamide) in patients with non-metastatic castration-resistant prostate cancer (CRPC), data published from the PROSPER study for Pfizer ...

... play a role? Twelve of the world’s leading KOLs from the US and Europe offer candid insights on four marketed therapies and nine Phase ... ? Could ImmunoGen’s antibody-drug conjugate IMGN853 have a potential role in ovarian cancer? KOLs debate the potential advantages and pitfalls to this novel approach ...

... hold a significant market share in the global colorectal cancer diagnostic and treatment market. This research study examines the current market ... clients in gaining faster and efficient understanding of the global colorectal cancer diagnostic and treatment market. Major industry players profiled as part of the ...

... on the new clinical data presented at the ASCO 2018 Gastrointestinal Cancers Symposium for Taiho Oncology’s Lonsurf (trifluridine and tipiracil); views ...

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) development landscape Develop ...

Global Radiation Oncology Market – Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018–2024 Overview: Radiation oncology is a medical specialty that uses high energy radiation ... healthcare awareness among the public. Market Analysis: The “Global Radiation Oncology” market is estimated to witness a ...

... intermediate- and high-risk non-muscle invasive bladder cancer (NMIBC); KOLs offering their updated opinions on the the supply status of the ... thoughts on PD-L1 expression and its future use as a biomarker in patients with bladder cancer? Do KOLs hold any other concerns about dual immunotherapy combinations ...

... events that have the potential to impact the treatment landscape of breast cancer (BC). Topics covered include expert opinions on: the FDA approval of Lynparza ...

... other cancer treating drugs. Cancer Monoclonal Antibodies Market Outline The market growth of cancer monoclonal antibodies is driven by increased prevalence of cancer worldwide. According to WHO, cancer is one of the leading cause of deaths worldwide. In 2012 ...

... Epiomic Epidemiology Forecast Report on Testicular Cancer in 24 Major Markets Testicular cancer is a relatively rare cancer; although it is the most commonly diagnosed cancer in males aged 20–34. There are two main types of testicular cancer ... testicular cancer patients. Identification of testicular cancer ...

... Epiomic Epidemiology Forecast Report on Thyroid Cancer in 21 Major Markets Thyroid cancer is a cancer originating from follicular or parafollicular thyroid cells. It is a relatively rare cancer ... the incident population of thyroid cancer patients. Identification of thyroid cancer patient sub-populations that ...

... patients with newly diagnosed, high-risk, metastatic hormone-sensitive prostate cancer (mHSPC); Bavarian Nordic’s announcement that it was discontinuing ... Xofigo (radium-223 dichloride) in combination with J&J's Zytiga in patients with prostate cancer as a result of an imbalance of more fractures and deaths in ...

... releases. The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

... are some of the factors hampering the market growth to an extent. Market Analysis: The “Global Cancer Diagnostics Market” is estimated to witness a CAGR ... The global cancer diagnostics market by application is segmented into lung cancer, breast cancer, Colorectal cancer, prostate cancer and others. Lung cancer ...

... releases. The Non-Small Cell Lung Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Non-Small Cell Lung Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

... releases. The Colon Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Colon Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...

According to Stratistics MRC, the Global Cancer Immunotherapy market is estimated at $62.57 billion in 2016 and is expected to reach $160.24 billion ... are the restraints hampering the market. On the other hand rise in clinical trials against different cancers in immunotherapy and elevated expansion prediction ...

... ) from North America and Europe on a variety of recent events in the colorectal cancer (CRC) market, including; Symphogen announcing detailed results from its ...

... on the therapy, global cancer gene therapy market is segmented as: Retroviral Therapy Adenoviral Therapy Based on the end-user, global cancer gene therapy market is segmented as: Hospitals Oncology institutes Biotechnological companies Clinical Research Labs Global cancer gene therapy market is highly ...

... to unawareness about prostate cancer symptoms is hampering the prostate cancer therapeutics market. Global prostate cancer therapeutics market segmented based on route of administration, drug class and distribution channel Based on drug class prostate cancer therapeutics market is segmented ...

... global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. ... photonics spectroscopy. Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, ...

... . Global bladder cancer treatment market is segmented based on cancer type, drug class, and distribution channel: Based on cancer type, global bladder cancer treatment market is segmented as: Transitional cell bladder cancer Invasive bladder cancer Superficial bladder cancer Squamous cell bladder cancer Other ...

Global Cancer Monoclonal Antibodies Market: Global cancer monoclonal antibodies market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for cancer monoclonal antibodies is projected to reach US$ XX Mn by 2023. A monoclonal antibody drug in cancer treatments ...

... Chronic Lymphocytic Leukemia Treatment Market: Global chronic lymphocytic leukemia treatment market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for chronic lymphocytic leukemia treatment is projected to reach US$ XX Mn by 2023. Chronic lymphocytic leukemia ...

Global Ovarian Cancer Treatment Market: Global ovarian cancer treatment market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of XX% over 2017-2023. Market for ovarian cancer treatment is projected to reach US$ XX Mn by 2023. Ovarian cancer is a type of cancer, which affects ovaries it ...

... the quantity of data is too high, so the artificial intelligence is being used to do that. Systems are making a significant difference ... to earlier cancer diagnosis.” Artificial Intelligence for Hospital Cancer Diagnostics Market Forecasts AI is set to become a sophisticated diagnostic aid, flagging ...

... Zytiga or Xtandi? Is the jury still out on immunotherapies in prostate cancer? Do KOLs believe that vaccine-based therapies or PD-1/PD-L1 checkpoint inhibitors ... Honorary Consultant in Clinical Oncology and Prostate Cancer Translational Research at The Institute of Cancer Research and The Royal Marsden, London ...

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

... panorama of industrial development and characteristics of the Breast Cancer Drug market. The Breast Cancer Drug market can be split based on product types, ... major applications, and important regions. Major Players in Breast Cancer Drug market are: Company 1 Company 2 Company 3 Company 4 Company ...

... panorama of industrial development and characteristics of the Cancer Genome Sequencing market. The Cancer Genome Sequencing market can be split based on product types ... , major applications, and important regions. Major Players in Cancer Genome Sequencing market are: Company 1 Company 2 Company 3 Company 4 ...

... you to establish a panorama of industrial development and characteristics of the Cancer Treatment Drugs market. The Cancer Treatment Drugs market can be split based on product types, major applications ...

... Cancer/Tumor Profiling market. The Cancer/Tumor Profiling market can be split based on product types, major applications, and important regions. Major Players in Cancer/Tumor Profiling market ... PCR Most widely used downstream fields of Cancer/Tumor Profiling market covered in this report are: Personalized ...

... of the Cervical Cancer Treatments Drug market. The Cervical Cancer Treatments Drug market can be split based on product types, major applications, and important regions. Major Players in Cervical Cancer Treatments Drug market are ...

... panorama of industrial development and characteristics of the Urinary Tract Cancer market. The Urinary Tract Cancer market can be split based on product types, ... major applications, and important regions. Major Players in Urinary Tract Cancer market are: Company 1 Company 2 Company 3 Company 4 ...

... are favoring the Asia Pacific market growth. Some of the key players in global Cancer Diagnostics market include Abbott Diagnostics, Agilent Technologies, Inc., Becton, Dickinson ...

... leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge ... Stains Lymphokines Supplier Shares, Sales and Volume Forecasts Sales and market shares of major cancer diagnostic product suppliers by ...

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

... and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

... and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

... suggests alternative business expansion strategies for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...

... and suggests alternative business expansion strategies for suppliers. RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...